This Week’s CGT News: Adaptimmune Therapeutics to Restructure After Acquisition
August 6, 2025
Our latest news roundup reports on a new cell and gene facility in Germany, cell therapy grants, and results from a global pharmacovigilance study on malignancies following CAR T treatment
4 min read